Clinical trials
Ascites trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
41 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2007 | 2 |
| 2008 | 1 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 3 |
| 2013 | 2 |
| 2014 | 2 |
| 2016 | 5 |
| 2017 | 5 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 4 |
| 2021 | 3 |
| 2022 | 3 |
| 2023 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 41 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Assiut University | 4 |
| Post Graduate Institute of Medical Education and Research, Chandigarh | 4 |
| University of Turin, Italy | 2 |
| Air Force Military Medical University, China | 1 |
| All India Institute of Medical Sciences | 1 |
| Asian Institute of Gastroenterology, India | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Changi General Hospital | 1 |
| Erasmus Medical Center | 1 |
| First People's Hospital of Foshan | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ascites | 41 |
| Liver Cirrhosis | 11 |
| Fibrosis | 7 |
| Pleural Effusion | 6 |
| Hepatorenal Syndrome | 3 |
| Hypertension, Portal | 3 |
| Acute Kidney Injury | 2 |
| Acute-On-Chronic Liver Failure | 2 |
| Neoplasms | 2 |
| Stomach Neoplasms | 2 |
Trials
Showing 51 to 41 of 41. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.